// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Assessment of a novel integrated training programme in tranthoracic echocardiography for junior cardiac physiologists in a regional cardiac centre

Laurence O’Toole - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Autonomic and vascular function characteristics in patients with atrial high rate episodes

Ahsan Khan - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of the introduction of an integrated multi-professional pathway for atrial fibrillation on long-term outcomes

Saadia Aslam - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Prognostic value of premature ventricular complexes during exercise stress testing in 56,000 individuals without known structural heart disease from UK biobank: is a single ectopic prognostic?

Stefan van Duijvenboden - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Premature ventricular complexes

N/A

Cardiac autonomic function influences in atrial fibrillation and hypertension

Ahsan Khan - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Adapting atrial fibrillation ablation to COVID times: the feasibility of very high power short duration ablation under mild conscious sedation

Gavin Chu - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

The resuscitation status of implantable cardioverter-defibrillator patients according to electronic health records: are we ignoring the device?

Robert Aldous - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Local application and utility of the MADIT-ICD benefit prediction score (MIBPS) in selection of patients at high risk of ‘sudden cardiac death’ suitable for primary prevention implantable cardioverter defibrillators

Nakul Chandan - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Optimal left ventricular lead positioning during cardiac resynchronisation therapy; a comparison of 2 methods

Panagiota Anna Chousou - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left bundle branch block

N/A

Insulin resistance is associated with QT prolongation in the 1946 british birth cohort

Christos Charalambous - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Negative impact of socioeconomic deprvation on clinical outcomes after cryoablation for atrial fibrillation - 18-month study

Yee Cheng Lau - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Amiodarone Hydrochloride

Five-year real world data on transvenous lead extraction (tle) in a single low volume centre

Kokhoon Tay - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

10-year follow-up of ICD implantation in non-ischaemic cardiomyopathy – an insight from real world practice in a large district general hospital

Heather Moore - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Rapid rollout of a pacemaker home monitoring service in somerset during the 2020 COVID-19 pandemic

Guy Furniss - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Pulmonary vein isolation for atrial fibrillation: ice ‘block’ vs ring of fire

Ashwin Reddy - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Socioeconomic deprivation score improves prediction of af recurrence and re-admission post AF ablation

Yee Cheng Lau - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Renal insufficiency

N/A

Drive-by physiology services: a novel model for the COVID-19 era

Roshan Xavier - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Role of cardiac autonomic function in pathophysiology of permanent AF

Ahsan Khan - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Detection of atrial high-rate episodes on remote monitoring of cardiac devices: are we following guidelines to determine the need for oral anti-coagulation?

Ronald Manorekang - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Painful left bundle brach block syndrome at rest treated with his-bundle pacing

Alex Touze - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Copyright © 2026. QuantiNova All rights reserved